Antibiotic prophylaxis in the management of vesicoureteral reflux.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

1. A rare case: Vesicoureteral reflux in Indonesian young adult with neurogenic bladder and chronic kidney disease stage 4.Annals of medicine and surgery (2012) · 2022
   Article
2. Prevalence of extended spectrum beta-lactamase production among uropathogens in south Mumbai and its antibiogram pattern.EXCLI journal · 2012
   Article
3. Medical versus surgical management for vesicoureteric reflux: the case for medical management.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2010
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract